UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041204
Receipt number R000047051
Scientific Title Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial
Date of disclosure of the study information 2020/07/24
Last modified on 2021/01/13 16:57:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial

Acronym

Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial

Scientific Title

Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial

Scientific Title:Acronym

Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial

Region

Japan


Condition

Condition

Atopic dermatitis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the improvement of atopic dermatitis after using a high performance shower head for 12 weeks with general shower head

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation prescribed in "Atopic Dermatitis Practice Guideline 2018" established by the Japanese Dermatological Association

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

High performance shower head

Interventions/Control_2

General shower head

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Men and women over the age of 18 diagnosed with atopic dermatitis
2) Those who can only use the shower during the test period
3) Those who have agreed to take a picture of the affected area
4) Those who can install the shower head specified in the test
5) Can obtain written consent

Key exclusion criteria

1) There are skin diseases other than atopic dermatitis such as burns
2) With tattoos and tattoos
3) May become pregnant during pregnancy or during the study period
4) Heart disease, cerebrovascular disease, arrhythmia, history of dizziness and being affected
5) Systolic blood pressure at screening is 170 mmHg or more or diastolic blood pressure is 110 mmHg or more. However, those taking antihypertensive drugs have systolic blood pressure of 150 mmHg or more.
6) May be in need of treatment during treatment or for malignant tumor
7) Surgical operation was performed within 6 months from the time of screening, or radiotherapy for malignant tumor.
8) The investigator determined that he was unsuitable as a researcher

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Takashima

Organization

Takashima Clinic

Division name

Critical Research

Zip code

5560011

Address

1-13-2, Namba-naka, naniwa-ku, Osaka

TEL

06-6606-9090

Email

f-sato@qolife.jp


Public contact

Name of contact person

1st name Fumihiko
Middle name
Last name Sato

Organization

Takashima Clinic

Division name

Critical Research

Zip code

5560011

Address

1-13-2, Namba-naka, naniwa-ku, Osaka

TEL

06-6606-9090

Homepage URL


Email

f-sato@qolife.jp


Sponsor or person

Institute

Takashima Clinic

Institute

Department

Personal name



Funding Source

Organization

Science, Co, ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Takashima Clinic Ethics Committee

Address

1-13-2, Namba-naka, naniwa-ku, Osaka

Tel

06-6606-9090

Email

f-sato@qolife.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

57

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 13 Day

Date of IRB

2020 Year 05 Month 13 Day

Anticipated trial start date

2020 Year 06 Month 15 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry

2020 Year 10 Month 31 Day

Date trial data considered complete

2021 Year 01 Month 12 Day

Date analysis concluded

2021 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 07 Month 24 Day

Last modified on

2021 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047051